IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptR-TXOfficial filing linked

Michael McCaul disclosed SELL $NFG

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$100K – $250K
Filed
2024-12-16
Trade date
2024-11-20
Disclosure lag
26 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Official public filing linked
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 26 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $100K – $250K, which is the public reporting band rather than an exact profit or loss figure.
41 nearby same-ticker disclosure appeared in the surrounding 30-day window.
5Committee context is available for Michael McCaul, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 1 lobbying filing.

Source

Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 8220706 · filed 2024-12-16 · disclosed 26d after transaction

Market context

NFG

Vs SPY: 20.5%

Factual flags

  • 1 lobbying filing linked to this ticker.
  • 1 nearby same-ticker disclosure in the surrounding 30-day window.
  • 165 trades filed on 2024-12-16 (batch dump)
  • Trade upper bound: $250,000

Member trail

Michael McCaul

U.S. House · TX-10

House Committee on Homeland SecurityHouse Committee on Foreign Affairs

Ticker trail

$NFG

Company metadata pending

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.